Dr. Reddy'S Pharmaceutical Company Annual Report on form 20-F for year ended March 31, 2007

PRLog (Press Release) - Oct 10, 2007 -
Dr. Reddy’s Laboratories Limited (NYSE: RDY) announces that the company’s annual report (http://www.drreddys.com/investors/annual_reports.htm) on Form 20-F for the year ended March 31, 2007 is available on its website ( http://www.drreddys.com ) and can be accessed by selecting 'SEC Filings' under the 'Investors' menu. ADS holders also have the ability to receive a hard copy of the company's complete audited financial statements free of charge upon request.

About Dr. Reddy’s:
Dr. Reddy's Laboratories (NYSE: RDY) is a global, vertically integrated pharmaceutical company with a presence across the value chain, producing and delivering safe, innovative, and high quality finished dosage forms, active pharmaceutical ingredients and biotechnology products, which are marketed to over 100 countries including US, Europe, Russia, India and China.

The Company conducts NCE drug discovery research in the areas of diabetes, cardiovascular, anti-infectives, and cancer. Its drug discovery effort is carried out at its research facilities in Atlanta, USA, and in Hyderabad, India.
For more details visit http://www.drreddys.com

Contact Information:
Investors and Financial Analysts:
Nikhil Shah at nikhilshah@drreddys.com or on +91-40-23731946 ext. 308
Media:
M Mythili at mythilim@drreddys.com or on +91-40-66511620

Photo:
http://www.prlog.org/10033746/1